We are live on
!
Find out more
Oragenics
OGEN
OGEN
13 hedge funds and large institutions have $9M invested in Oragenics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
8% more funds holding
Funds holding: 12 → 13 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
14% less capital invested
Capital invested by funds: $10.5M → $9M (-$1.46M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$24K |
| 2 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$12K |
| 3 |
Squarepoint
New York
|
+$12K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$528K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$120K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$17K |
